Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001193125-20-033240
Filing Date
2020-02-12
Accepted
2020-02-12 16:18:06
Documents
2
Period of Report
2020-02-12

Document Format Files

Seq Description Document Type Size
1 6-K d886294d6k.htm 6-K 11786
2 EX-1.1 d886294dex11.htm EX-1.1 284472
  Complete submission text file 0001193125-20-033240.txt   297230
Mailing Address TUBORG BOULEVARD 12 HELLERUP G7 DK-2900
Business Address TUBORG BOULEVARD 12 HELLERUP G7 DK-2900 45 70 22 22 44
Ascendis Pharma A/S (Filer) CIK: 0001612042 (see all company filings)

EIN.: 000000000 | State of Incorp.: G7 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-36815 | Film No.: 20604345
SIC: 2834 Pharmaceutical Preparations